TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th July 27, 1984